See more : Unifique Telecomunicações S.A. (FIQE3.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Cannasouth Limited (CBD.NZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannasouth Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Bel Fuse Inc. (BELFB) Income Statement Analysis – Financial Results
- Adairs Limited (ADH.AX) Income Statement Analysis – Financial Results
- Charlton Aria Acquisition Corporation (CHARU) Income Statement Analysis – Financial Results
- China Intelligence Information Systems, Inc. (IICN) Income Statement Analysis – Financial Results
- Goosehead Insurance, Inc (GSHD) Income Statement Analysis – Financial Results
Cannasouth Limited (CBD.NZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannasouth.co.nz
About Cannasouth Limited
Cannasouth Limited, a biopharmaceutical company, engages in the research, development, manufacture, and supply of cannabinoid medicines and cannabis biomass in New Zealand. The company was incorporated in 2018 and is based in Hamilton, New Zealand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 955.55K | 140.60K | 1.30M | 131.14K | 53.39K |
| Cost of Revenue | 2.18M | 3.26M | 253.92K | 0.00 | 0.00 |
| Gross Profit | -1.22M | -3.12M | 1.05M | 131.14K | 53.39K |
| Gross Profit Ratio | -127.65% | -2,219.46% | 80.49% | 100.00% | 100.00% |
| Research & Development | 767.29K | 748.47K | 870.33K | 721.24K | 302.07K |
| General & Administrative | 6.71M | 3.11M | 2.53M | 2.77M | 1.72M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.71M | 3.11M | 2.53M | 2.77M | 1.72M |
| Other Expenses | 0.00 | 98.43K | 2.19M | 0.00 | 0.00 |
| Operating Expenses | 7.48M | 3.86M | 3.41M | 3.49M | 2.24M |
| Cost & Expenses | 9.66M | 7.12M | 3.66M | 3.49M | 2.24M |
| Interest Income | 106.46K | 0.00 | 46.70K | 178.24K | 71.68K |
| Interest Expense | 215.02K | 299.21K | 79.67K | 29.21K | 28.24K |
| Depreciation & Amortization | 167.90K | 1.14M | 8.14K | 3.50K | 164.14K |
| EBITDA | -8.59M | -6.48M | -2.51M | -3.26M | -1.99M |
| EBITDA Ratio | -899.28% | -4,963.02% | -117.05% | -2,629.21% | -3,725.70% |
| Operating Income | -8.70M | -8.12M | -1.53M | -3.45M | -2.15M |
| Operating Income Ratio | -910.42% | -5,774.51% | -117.67% | -2,631.88% | -4,033.12% |
| Total Other Income/Expenses | -108.57K | 194.39K | -555.04K | -125.28K | -28.24K |
| Income Before Tax | -8.81M | -7.91M | -1.61M | -3.48M | -2.18M |
| Income Before Tax Ratio | -921.78% | -5,627.89% | -123.79% | -2,654.15% | -4,086.00% |
| Income Tax Expense | 0.00 | -547.11K | 5.17K | 70.95K | -8.80K |
| Net Income | -8.81M | -8.21M | -1.62M | -3.55M | -2.18M |
| Net Income Ratio | -922.37% | -5,837.45% | -124.19% | -2,708.26% | -4,086.00% |
| EPS | -0.04 | -0.06 | -0.01 | -0.03 | -0.02 |
| EPS Diluted | -0.04 | -0.06 | -0.01 | -0.03 | -0.02 |
| Weighted Avg Shares Out | 250.05M | 143.48M | 133.31M | 121.37M | 97.15M |
| Weighted Avg Shares Out (Dil) | 250.05M | 143.48M | 133.31M | 121.37M | 97.15M |
Source: https://incomestatements.info
Category: Stock Reports